Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Aug-24 5:23 PM View:  | MacK Gene CFO and Interim CEO | Gain Therapeutics, Inc. (GANX) | 09-Aug-24 | Private Purchase | 14,400 | $1.01 | $14,544.00 | 100% 0 to 14.4K | |
| 12-Aug-24 5:23 PM View: | Islam Khalid Executive Chairman Director | Gain Therapeutics, Inc. (GANX) | 09-Aug-24 | Private Purchase | 50,000 | $1.00 | $49,940.00 | 6% 880.78K to 930.78K | |
| 01-Jul-24 5:00 PM View: | Richman Eric I Director | Gain Therapeutics, Inc. (GANX) | 01-Jul-24 | Private Purchase | 17,000 | $1.22 | $20,670.00 | 6% 287.46K to 304.46K | |
| 01-Apr-24 4:01 PM View: | Riley Jeffrey Scott Director | Gain Therapeutics, Inc. (GANX) | 28-Mar-24 | Private Purchase | 30,000 | $3.86 | $115,770.00 | 100% 0 to 30.0K | |
| 28-Mar-24 9:00 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 26-Mar-24 | Payment of Exercise | 6,085 | $4.06 | $24,705.10 | (22%) 27.23K to 21.14K | |
| 28-Mar-24 9:00 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 26-Mar-24 | Option Exercise | 20,212 | -- | -- | 288% 7.01K to 27.23K | |
| 22-Dec-23 4:17 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 21-Dec-23 | Option Sale | 206 | $2.46 | $506.76 | (4%) 5.49K to 5.29K | |
| 22-Dec-23 4:17 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 20-Dec-23 | Option Exercise | 637 | -- | -- | 13% 4.86K to 5.49K | |
| 14-Dec-23 4:01 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 07-Dec-23 | Sale | 1,820 | $2.50 | $4,550.00 | (27%) 6.67K to 4.86K | |
| 03-Oct-23 4:36 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 01-Oct-23 | Option Exercise | 825 | -- | -- | 14% 5.85K to 6.67K | |
| 22-Sep-23 4:34 PM View: | Richman Eric I Director | Gain Therapeutics, Inc. (GANX) | 20-Sep-23 | Option Exercise | 54,900 | -- | -- | 24% 232.56K to 287.46K | |
| 22-Sep-23 4:34 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 20-Sep-23 | Option Exercise | 2,550 | -- | -- | 77% 3.3K to 5.85K | |
| 05-Jul-23 4:18 PM View: | Alder Matthias Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 01-Jul-23 | Option Exercise | 3,300 | -- | -- | 100% 0 to 3.3K | |
| 27-May-22 4:10 PM View: | Richman Eric I Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 25-May-22 | Private Purchase | 2,482 | $2.58 | $6,403.56 | 1% 230.08K to 232.56K | |
| 23-May-22 4:41 PM View: | Richman Eric I Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 20-May-22 | Purchase | 9,256 | $2.83 | $26,194.50 | 4% 220.82K to 230.08K | |
| 23-May-22 4:41 PM View: | Richman Eric I Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 19-May-22 | Private Purchase | 4,000 | $2.71 | $10,840.00 | 2% 216.82K to 220.82K | |
| 17-Aug-21 9:03 PM View: | Richman Eric I Chief Executive Officer Director | Gain Therapeutics, Inc. (GANX) | 16-Aug-21 | Option Exercise | 4,922 | $7.87 | $38,716.50 | 2% 211.9K to 216.82K |
